MedTrace Logo

Use of Stress-CMR Using Regadenoson and GE-267 in Adult Patients with Known or Suspected Coronary Artery Disease

NCT06246188 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2025-03-25

No results posted yet for this study

Summary

Stress cardiac MRI is crucial for diagnosing coronary artery disease in adults. Currently, it is mainly performed with vasodilators in specialized centers. Introducing mobile CMR units could increase accessibility, especially in rural areas, potentially reducing unnecessary invasive procedures. The objectives include demonstrating the feasibility of mobile stress perfusion CMR, detecting CAD using Regadenoson, and evaluating the image quality of GE-267 in real-world scenarios.

Conditions

Interventions

DIAGNOSTIC_TEST

Cardiac MRI using Regadenoson and GE-267

Performing stress-cardiac MRI for clinical diagnostic in adult patients with suspected coronary artery disease

Sponsors & Collaborators

  • GE Healthcare

    collaborator INDUSTRY

  • German Heart Institute

    lead OTHER

Principal Investigators

  • Sebastian Kelle, Prof. Dr. · Deutsches Herzzentrum der Charité

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06246188 on ClinicalTrials.gov